watch nowPresident Donald Trump's move Thursday to sign an executive order easing federal restrictions on marijuana — and clearing the way for a Medicare pilot program covering CBD — caps a coordinated, yearlong push by the cannabis industry that combined traditional lobbying, sizable political donations, data-driven messaging and direct outreach to the president's inner circle, industry insiders told CNBC.Despite long-standing GOP opposition to loosening drug laws — including a small wave of bills from law ...

Our Brandon Gomez has more on why that move came about and why now. Hey Brandon, >> instead investors clearly seeing more haze ahead. Still, the group holding solid gains monthto date.Let's start with what actually happened yesterday. President Trump signed an executive order directing the DEA to reclassify cannabis from schedule 1 to schedule 3. Now that eases restrictions on medical research, banking, and taxes.The administration also launched a Medicare pilot program allowing some seniors starting in Apr ...

Put this in your pipe and smoke it: Donald Trump just legalized marijuana across the US. As On The Money has been reporting since April, our famously drug-and-drink-averse president has been inching ever closer to making marijuana significantly less criminal in the eyes of the federal government. On Thursday, it finally happened. He signed an executive order to “reclassify” weed to a “Schedule III” drug – throwing it into the same category as codeine-laced Tylenol, testosterone and anabolic steroids. That’s ...

I'd like to see the money that is going to the insurance companies by the hundreds of billions of dollars. The stocks are up through the roof over a fairly short period of time because they're getting vast amounts of money. I want that money to go to the people directly and let the people buy their own health care and uh they'll get much better health care than they get with the unaffordable care act. let the money go directly to the people and let them buy their own healthcare.>> President Trump along with ...

President Trump has signed an executive order to reclassify marijuana from a schedule one to a schedule three drug. While not making it fully legal, it would ease federal restrictions. Joining us right now with what this means for the marijuana industry and personal consumption is Kevin Sabbat.He is the CEO of Smart Approaches to Marijuana, a former White House Drug Policy Advisor, and he's the author of One Nation Under the Influence. Kevin, first of all, thank you uh for being here. It's been a while sinc ...

President Donald Trump's move to relax federal marijuana regulations has been welcomed by the US cannabis industry, but it has not changed the sector's most persistent challenge. Access to mainstream ... ...

Breaking news. It hasn't even been two hours since President Trump signed an executive order reclassifying marijuana. And the pot adjacent play, Scott's Miracle Grow, is making news regarding its Hawthorne subsidiary that sells cannabis growing supplies such as light systems and plant nutrients to marijuana growers.Scots talking about its plan to combine that subsidiary with a dedicated Pure Play cannabis company next year. Well, right there in the room, Scott's Miracle Grow CEO Jim Hagadorn was with the pr ...

President Donald Trump signed an executive order on Thursday, directing federal agencies to loosen regulations on marijuana, marking one of the most significant shifts in federal cannabis policy in decades.To Promote ‘Medical Uses’ of MarijuanaThe order directs U.S. Attorney General Pam Bondi to expedite the process of rescheduling marijuana to Schedule III under the Controlled Substances Act. This would put the popular psychoactive substance right alongside other common painkillers, which means it still fa ...

U.S. President Donald Trump's move to relax marijuana regulations could ease some burden for cannabis companies, but will likely keep doors to access capital from big banks closed, experts said. ...

文章核心观点 - 美国总统签署的行政命令是自20世纪70年代大麻被列入管制物质以来首次有意义的政策改革 具有里程碑意义 该命令并未将大麻合法化 但为医学研究打开了大门 并减轻了行业公司的惩罚性税收负担 [1][2] 政策影响与行业意义 - 政策改革为医学研究扫清了障碍 并终止了行业公司所承受的惩罚性税收负担 [2] - 白宫和行政命令的核心精神是建立一个安全、受监管、经过测试的产品市场 数千万美国人正在使用医用大麻 全美40个州已建立了复杂且具体的运营项目 [6][7] - 政策方向是朝着建立一个监管严格但可及的医用大麻市场迈进 [8] 行业后续发展步骤 - 国会成员期待总统的政策信号 以推进更安全的银行业务法案 这是下一个渐进步骤 [3] - 更安全的银行业务将降低银行业壁垒 并可能促使纳斯达克和纽约证券交易所接受大麻公司在美上市 [4] 市场反应与细分领域 - 市场在5天内上涨150%后 当日回调了20% 市场对CBD相关新闻和潜在冲突有所反应 [5] - 公司高管不担心CBD方面的影响 认为行政命令中关于建立受监管市场的具体措辞是明确且一致的 [5][6]